ChemicalBook >> CAS DataBase List >>Erythromycin A Oxime
Erythromycin A Oxime
- CAS No.
- 111321-02-9
- Chemical Name:
- Erythromycin A Oxime
- Synonyms
- (9E)-ErythroMycin A OxiMe;Erythromycin A Oxime;(E)-Erythromycin oxime;Erythromycin Impurity J;AzithroMycin iMpurity 20;Azithromycin Impurity 19;Erythromycin Impurity S;Azithromycin impurity 09;Azithromycin CP Impurity S;Erythromycin, 9-oxime, (9E)-
- CBNumber:
- CB51176305
- Molecular Formula:
- C37H68N2O13
- Molecular Weight:
- 748.95
- MDL Number:
- MFCD08062410
- MOL File:
- 111321-02-9.mol
Last updated:2023-06-08 09:03:09
Melting point | 156-166 °C |
---|---|
Boiling point | 841.0±65.0 °C(Predicted) |
Density | 1.28±0.1 g/cm3(Predicted) |
storage temp. | Refrigerator |
solubility | Chloroform (Slightly), DMSO (Slightly), Ethanol (Slightly), Methanol (Slightly) |
form | Solid |
pka | 11.96±0.70(Predicted) |
color | White to Off-White |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS09 |
---|---|
Hazard statements | H401-H411 |
Precautionary statements | P273-P391-P501 |
Erythromycin A Oxime price More Price(8)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Cayman Chemical | 27966 | 9(E)-Erythromycin A oxime | 111321-02-9 | 5mg | $116 | 2024-03-01 | Buy |
Cayman Chemical | 27966 | 9(E)-Erythromycin A oxime | 111321-02-9 | 25mg | $494 | 2024-03-01 | Buy |
Cayman Chemical | 27966 | 9(E)-Erythromycin A oxime | 111321-02-9 | 1mg | $32 | 2024-03-01 | Buy |
Cayman Chemical | 27966 | 9(E)-Erythromycin A oxime | 111321-02-9 | 10mg | $214 | 2024-03-01 | Buy |
Usbiological | 257296 | Erythromycin A oxime | 111321-02-9 | 10g | $980 | 2021-12-16 | Buy |
Erythromycin A Oxime Chemical Properties,Uses,Production
Description
(9E)-Erythromycin A oxime is a metabolite of the semisynthetic antibiotic roxithromycin .
Chemical Properties
Off-White Solid
Uses
Intermediate of Azithromycin. Antibacterial agent.
Uses
Erythromycin A 9-oxime is a semi-synthetic analogue of erythromycin prepared as means of overcoming acid lability and improving oral absorption of erythromycin A while retaining comparable antibacterial and potency. Although not developed as a commercial product, erythromycin oxime was pivotal in the development of the ring expanded aza-erythromycins (e.g. azithromycin) and the oxime ethers (e.g. roxithromycin).
Uses
(9E)-Erythromycin A Oxime is a metabolite of Roxithromycin (R700850) in humans. It has anti-Helicobacter pylori activity
Erythromycin A Oxime Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 96)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Biochempartner | 0086-13720134139 | candy@biochempartner.com | CHINA | 967 | 58 |
Hubei Jusheng Technology Co.,Ltd. | 18871490254 | linda@hubeijusheng.com | CHINA | 28180 | 58 |
ANHUI WITOP BIOTECH CO., LTD | +8615255079626 | eric@witopchemical.com | China | 23556 | 58 |
Hangzhou Huarong Pharm Co., Ltd. | 571-86758373 +8613588754946 | sales@huarongpharm.com | CHINA | 3149 | 58 |
CD Chemical Group Limited | +8615986615575 | info@codchem.com | China | 20356 | 58 |
Hefei TNJ Chemical Industry Co.,Ltd. | 0551-65418684 +8618949823763 | sales@tnjchem.com | China | 25363 | 58 |
ZHEJIANG JIUZHOU CHEM CO., LTD | +86-0576225566889 +86-13454675544 | admin@jiuzhou-chem.com;jamie@jiuzhou-chem.com;alice@jiuzhou-chem.com | China | 19949 | 58 |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 | masar@topule.com | China | 8474 | 58 |
LEAPCHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 43348 | 58 |
Wuhan Jingkang en Biomedical Technology Co., Ltd | +8613720134139 | orders@jknbiochem.com | China | 4691 | 58 |
111321-02-9(Erythromycin A Oxime)Related Search:
Roxithromycin EP Impurity D
erythronolide B
Azithromycin F
Azithromycin C
ErythroMycin A 9,11-IMino Ether
3'-N-DesMethyl-3'-N-tosyl AzithroMycin
N'-DesMethyl AzithroMycin
AzithroMycin N-Oxide
N',N'-Di(desmethyl) Azithromycin
AZITHROMYCIN IMPURITY B
1of4
Erythromycin A Oxime
Erythromycin Impurity J
(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9
Azithromycin Impurity S ((9E)-Erythromycin A Oxime)
(9E)-Erythromycin A Oxime
Roxithromycin EP Impurity C
Roxithromycin EP Impurity C (Erythromycin Impurity J)
(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2R,3R,4S,6R)-
4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-
yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-
hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)
oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyl
oxacyclotetradecan-2-one
Azithromycin Impurity S(Roxithromycin EP Impurity C)
(E)-Erythromycin oxime
Erythromycin Impurity J (Roxithromycin EP Impurity C)
Roxithromycin EP Impurity C/(9E)-Erythromycin A Oxime/(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethylt
AzithroMycin iMpurity 20
(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2R,3R,4S,6R)- 4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2- yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5- hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl) oxy)-10-(hydroxyimino)-3,5
Azithromycin Impurity 19
(3R,4S,5S,6R,7R,9R,11S,12S,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9
(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2R,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9
Erythromycin, 9-oxime, (9E)-
Roxithromycin EP Impurity C (Erythromycin A 9-Oxime (E-Isomer))
(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
Azithromycin CP Impurity S
(9E)-Erythromycin A Oxime,Erythromycin A (E)-9-oxime,Clarithromycin Impurity J(EP),Roxithromycin Impurity C
(9E)-ErythroMycin A OxiMe
Erythromycin Impurity S
(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one (Roxithromycin Impurity)
Azithromycin impurity 09
Clarithromycin EP Impurity J(Roxithromycin Impurity C)
Clarithromycin EP Impurity J(Roxithromycin EP Impurity C)
111321-02-9
Intermediates & Fine Chemicals
Pharmaceuticals
Chiral Reagents, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals